HIV-1 gp120 Activates the STAT3/Interleukin-6 Axis in Primary Human Monocyte-Derived Dendritic Cells
出版年份 2014 全文链接
标题
HIV-1 gp120 Activates the STAT3/Interleukin-6 Axis in Primary Human Monocyte-Derived Dendritic Cells
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 88, Issue 19, Pages 11045-11055
出版商
American Society for Microbiology
发表日期
2014-07-10
DOI
10.1128/jvi.00307-14
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- STAT3-silenced human dendritic cells have an enhanced ability to prime IFNγ production by both αβ and γδ T lymphocytes
- (2014) Isabella Sanseverino et al. IMMUNOBIOLOGY
- Signaling Mechanism of HIV-1 gp120 and Virion-Induced IL-1 Release in Primary Human Macrophages
- (2014) R. Cheung et al. JOURNAL OF IMMUNOLOGY
- Dendritic cell dysregulation during HIV-1 infection
- (2013) Elizabeth Miller et al. IMMUNOLOGICAL REVIEWS
- HIV Type 1 gp120–Induced Expansion of Myeloid Derived Suppressor Cells Is Dependent on Interleukin 6 and Suppresses Immunity
- (2013) Ankita Garg et al. JOURNAL OF INFECTIOUS DISEASES
- Unknown
- (2013) Karlhans Che et al. MOLECULAR MEDICINE
- HIV-1 Gp120 Protein Downregulates Nef Induced IL-6 Release in Immature Dentritic Cells through Interplay of DC-SIGN
- (2013) Roni Sarkar et al. PLoS One
- Nuclear Phosphoinositide-Specific Phospholipase C β1 Controls Cytoplasmic CCL2 mRNA Levels in HIV-1 gp120-Stimulated Primary Human Macrophages
- (2013) Francesca Spadaro et al. PLoS One
- Dendritic cells in progression and pathology of HIV infection
- (2013) Olivier Manches et al. TRENDS IN IMMUNOLOGY
- Revisiting the Specificity of Small Molecule Inhibitors: The Example of Stattic in Dendritic Cells
- (2012) Isabella Sanseverino et al. CHEMISTRY & BIOLOGY
- NF-κB Repression by PIAS3 Mediated RelA SUMOylation
- (2012) Yuangang Liu et al. PLoS One
- Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3
- (2011) Christian Ehlting et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors
- (2011) T. Iwata-Kajihara et al. JOURNAL OF IMMUNOLOGY
- HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA
- (2011) Ankit Shah et al. PLoS One
- Human Immunodeficiency Virus-1 Inhibition of Immunoamphisomes in Dendritic Cells Impairs Early Innate and Adaptive Immune Responses
- (2010) Fabien P. Blanchet et al. IMMUNITY
- Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function
- (2010) Jessica A. Melillo et al. JOURNAL OF IMMUNOLOGY
- HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1
- (2009) A. R. Anand et al. BLOOD
- gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis
- (2009) R. Bruno et al. GUT
- Immunomodulation by semi-mature dendritic cells: A novel role of Toll-like receptors and interleukin-6
- (2009) Julia-Stefanie Frick et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Tristetraprolin Is Required for Full Anti-Inflammatory Response of Murine Macrophages to IL-10
- (2009) B. Schaljo et al. JOURNAL OF IMMUNOLOGY
- Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages
- (2008) L. Fantuzzi et al. BLOOD
- The Signal Transducer STAT5 Inhibits Plasmacytoid Dendritic Cell Development by Suppressing Transcription Factor IRF8
- (2008) Eiji Esashi et al. IMMUNITY
- HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood–brain barrier: modulatory effects of STAT1 signaling
- (2008) Bo Yang et al. MICROVASCULAR RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started